CU Anschutz In The News

The Fulginiti Gallery seems content to address its primary concern, using art to teach the finer points of health care to the future doctors and nurses who go to this outpost of the University of Colorado to study medicine. The theory goes that artists, with their unique and compelling way of saying things, can instruct in a way that scientists cannot, pushing students to think profoundly about the emotional experiences of the patients they will serve. It is part of the larger mission of CU’s Center for Bioethics and Humanities.

Researchers still don’t know how the recent outbreak of bird flu spread to cattle, but the leading theory is that it has to do with milking machines that could be carrying the virus, Jenna Guthmiller, an assistant professor of immunology and microbiology at the University of Colorado School of Medicine, said in the university’s journal. She said high levels of the virus have been found in the cows’ udders, and the infection appears restricted to dairy cows, which furthers this possibility.

Following a competitive national search, the University of Colorado Anschutz Medical Campus is proud to announce that John H. Sampson, MD, PhD, MHSc, MBA, has been selected as the University of Colorado School of Medicine Dean and Vice Chancellor for Health Affairs for CU Anschutz, effective July 1, 2024. He will bring more than two decades of clinical and academic leadership to the CU School of Medicine, aiming to expand on the transformational tenure of current Dean John J. Reilly, Jr., MD.

Scientists who study Down syndrome say people with the condition live rich and fulfilling lives, but they also experience “a very atypical form of aging,” said Joaquin Espinosa, executive director of the Linda Crnic Institute for Down Syndrome at the University of Colorado Anschutz Medical Campus. For researchers, “that could be super-rich to understand aging in general.”

In its latest guidelines on colon cancer, the Cancer Network panel noted that not everyone with a risky gene variant gets sick from the drug, and that lower dosing for patients carrying such a variant could rob them of a cure or remission. Many doctors on the panel, including the University of Colorado School of Medicine oncologist Wells Messersmith, have said they have never witnessed a 5-FU death.

Dr. Benjamin Honigman is a retired University of Colorado School of Medicine who has spent his career studying the impacts of altitude on the human body. He’s currently the chair of an advisory group with the High Altitude Research Center at the CommonSpirit St. Anthony Summit Hospital in Frisco. “[The] High Altitude Research Center is involved in a project that we call the Healthy Summit Project, and what we're trying to do is determine what the impact of living at eight to 10,000 feet in Summit County is on common diseases. Diseases such as heart disease or lung disease, diabetes, sleep disorders, those sorts of things,” he said.

Dr. Matt Mishkind, a researcher who studies technological innovation in behavioral health as deputy director of the University of Colorado's Helen and Arthur E. Johnson Depression Center, said the failure to disclose issues or negative outcomes in a project like California's may lead to further user harm, if consumers are never informed of the possible risks of using a platform. Mishkind was not involved in Tech Suite or familiar with it prior to speaking to Mashable. 

“We wanted to understand which risk factors were the top contributors to stroke risk among young adults,” said study lead author Michelle Leppert, M.D., M.S., M.B.A., FAHA, an assistant professor of neurology at the University of Colorado School of Medicine in Aurora, Colorado.